Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More

November 14, 10:57 AM

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.

ACRX

3 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

November 12, 1:49 PM

ABSI

5 minute read

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

By Shanthi Rexaline

October 1, 7:56 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30)

ADMA

1 minute read

Vaccitech Q2 EPS $(0.64) Down From $(0.45) YoY

By Bill Haddad

August 12, 8:25 AM

Vaccitech (NASDAQ:VACC) reported quarterly losses of $(0.64) per share. This is a 42.22 percent decrease over losses of $(0.45) per share from the same period last year.

VACC

1 minute read

Bullish Arbutus Biopharma Analyst Breaks Down Pipeline Opportunity

By Nikhil Dayal

July 6, 4:51 PM

The expected start of combination clinical trials has H.C. Wainwright bullish on shares of Arbutus Biopharma Corp. (NASDAQ: ABUS). The Arbutus Analyst: Ed Arce raffirmed a Buy rating on shares of Arbutus Biopharma Corp. with a $10 price target.

ABUS

1 minute read

Arbutus Biopharma, Vaccitech Team Up To Develop Combo Treatment For Hepatitis B

By Vandana Singh

July 6, 10:19 AM

Arbutus Biopharma Corporation (NASDAQ:ABUS) and Vaccitech plc (NASDAQ:VACC) have collaborated to evaluate combination treatment for chronic hepatitis B virus who are already receiving…

ABUS

6 minute read

72 Biggest Movers From Yesterday

By Lisa Levin

July 1, 4:31 AM

Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share.

ALT

1 minute read

Vaccitech Q1 EPS $(1.90)

By Benzinga Newsdesk

June 14, 5:58 PM

Vaccitech (NASDAQ:VACC) reported quarterly losses of $(1.90) per share.

VACC

2 minute read

Uncategorized

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation

By Shanthi Rexaline

May 23, 10:05 AM

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.

ASND

5 minute read

Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline

May 14, 7:59 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL